Lilly France

Lilly France, established in 1962, operates as a specialized pharmaceutical manufacturing company within the healthcare sector. As an integral component of the global Eli Lilly organization, its core mission involves the development and production of innovative medical treatments and comprehensive healthcare solutions. The company dedicates its resources to creating pharmaceutical products designed to address a wide spectrum of therapeutic areas and diverse health conditions, thereby contributing to advancements in patient care.

With a workforce ranging from 1,000 to 5,000 employees, Lilly France maintains a significant operational footprint across two distinct locations. Its advanced manufacturing facilities are geared towards the precise production of pharmaceutical goods, complemented by robust research and commercial activities. These functions ensure the effective development, distribution, and market access of its medical innovations. To understand the expertise behind these operations, one can Meet Lilly France's team, a group committed to driving scientific progress and operational excellence in the pharmaceutical field.

Generating $702.1 million in revenue, Lilly France holds a strategic position within the highly competitive global pharmaceutical market. It engages with key industry leaders such as Pfizer, Novo Nordisk, Merck, and Novartis, among other major competitors. The company's focus on specific therapeutic areas and its role within the broader Eli Lilly portfolio highlight its market influence. Headquartered in Fegersheim, France, its European operations are central to its strategy for delivering critical healthcare solutions worldwide.